Download Files:
PCSK9-IN-2
SKU
HY-132897-Get quote
Category Reference compound
Tags Cardiovascular Disease, Metabolic Enzyme/Protease, Ser/Thr Protease
Products Details
Product Description
– PCSK9-IN-2 is a novel small molecule inhibitor of PCSK9-LDLR protein–protein interaction (PPI) with an IC50 value of 7.57 μM.
Web ID
– HY-132897
Shipping
– Room temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C26H32N6O6
References
– [1]Sun H, et al. Discovery of Novel Small Molecule Inhibitors Disrupting the PCSK9-LDLR Interaction. J Chem Inf Model. 2021 Oct 25;61(10):5269-5279.
CAS Number
– 2099167-44-7
Molecular Weight
– 524.57
SMILES
– O=C1NCCCC[C@H]1N[C@@H]2CC(N(C2=O)C3=CC=C(C=C3)N4C(C[C@H](C4=O)N[C@@H]5CCCCNC5=O)=O)=O
Clinical Information
– No Development Reported
Research Area
– Cardiovascular Disease
Solubility
– 10 mM in DMSO
Target
– Ser/Thr Protease
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.